Inergetics, Inc. (OTC:NRTI) has been on an uptrend for more than a week now, which would have seemed perfectly all right had it not been for the total lack of corporate news. The latter has not resulted in mounting suspicions of insider play, a P&D, or even leakages of confidential information.
Yesterday, NRTI went up 32% to a 24-week high of $0.33 per share. The spike in volume was even more impressive as more than 900 thousand shares of common NRTI stock changed hands, setting a new six-month record for the company. Thus, NRTI continued the positive chart run it started on Jan. 13, keeping a total eclipse on its business operations. At least, this is how some traders perceive the current situation about NRTI.
Inergetics, Inc. specializes in developing patent protected nutritional products designed to improve the health, performance and quality of life of consumers, athletes, etc. At present, the company offers two basic product lines – Surgex(TM) and Resurgex(TM), both of which are expected to improve the health condition of all recipients.
NRTI’s latest SEC filing is a full-blown 10-Q form covering the quarter ended Sept. 30, 2011. As of that date, the company’s balance sheet contains the following numbers among others:
- cash and cash equivalents of $0.5M;
- current assets of $0.94M as opposed to $0.38M in Q4 2010;
- current liabilities of $3.46M in comparison with $9.02M a/o Dec. 31, 2010;
- quarterly revenue of $14.5K vs. $9.4K in Q3 2010;
- quarterly net loss of $1.63M as compared to $0.95M in Q3 2010.
